Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder

World Journal of Biological Psychiatry

Volumn 15, Issue 2, 2014, Pages 135-144

  Mamdani, Firoza ^a,b   Berlim, Marcelo T ^a   Beaulieu, Marie Martine ^a   Turecki, Gustavo ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarkers; Citalopram; Immune response genes; Major depressive disorder; Peripheral gene expression

Indexed keywords

CITALOPRAM; BIOLOGICAL MARKER; SEROTONIN UPTAKE INHIBITOR; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SMAD7 PROTEIN; SMAD7 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; DOWN REGULATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; GENE; GENE EXPRESSION; GENE ONTOLOGY; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; IMMUNE RESPONSE GENE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHARMACOGENOMICS; PSEUDOGENE; REMISSION; SIGLECP3 GENE; SMAD7 GENE; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD; DEPRESSIVE DISORDER, MAJOR; GENETICS; PHARMACOGENETICS; PROCEDURES;

ADULT; BIOLOGICAL MARKERS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMANS; MALE; PHARMACOGENETICS; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS; SMAD7 PROTEIN; TREATMENT OUTCOME;

EID: 84893842308     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2013.766762     Document Type: Article

References (50)

1. Akiskal HS. 1982. Factors associated with incomplete recovery in primary depressive illness. J Clin Psychiatry 43 : 266-271. (Pubitemid 12042977)
2. Alda M , Grof P , Grof E , Zvolsky P , Walsh M. 1994. Mode of inheritance in families of patients with lithium-responsive affective disorders. Acta Psychiatr Scand 90 : 304-310. (Pubitemid 24303601)
3. Anisman H , Merali Z. 2003. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 35 : 2-11. (Pubitemid 36356868)
4. Asano Y , Ihn H , Yamane K , Kubo M , Tamaki K. 2004. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fi broblasts. J Clin Invest 113 : 253-264. (Pubitemid 38544210)
5. Belzeaux R , Formisano-Treziny C , Loundou A , Boyer L , Gabert J , Samuelian JC , et al. 2010. Clinical variations modulate patterns of gene expression and defi ne blood biomarkers in major depression. J Psychiatr Res 44 : 1205-1213.
6. Carlin AF , Uchiyama S , Chang YC , Lewis AL , Nizet V , Varki A. 2009. Molecular mimicry of host sialylated glycans allows bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113 : 3333-3336.
7. Cattaneo A, Gennarelli M , Uher R , Breen G , Farmer A , Aitchison KJ , et al. 2013. Candidate Genes Expression Profi le Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets'. Neuropsychopharmacology 38 : 377-85.
8. Chang JC , Wooten EC , Tsimelzon A , Hilsenbeck SG , Gutierrez MC , Elledge R , et al. 2003. Gene expression profi ling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362 : 362-369. (Pubitemid 36957839)
9. Chen GY , Tang J , Zheng P , Liu Y. 2009. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323 : 1722-1725.
10. Crocker PR , Paulson JC , Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol 7 : 255-266. (Pubitemid 46480955)
11. Dennis G Jr, Sherman BT , Hosack DA , Yang J , Gao W , Lane HC , et al. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 : 3.
12. Franchini L , Serretti A , Gasperini M , Smeraldi E. 1998. Familial concordance of fl uvoxamine response as a tool for differentiating mood disorder pedigrees. J Psychiatr Res 32 : 255-259. (Pubitemid 28410114)
13. Gladkevich A , Kauffman HF , Korf J. 2004. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28 : 559-576. (Pubitemid 38490769)
14. Glatt SJ , Everall IP , Kremen WS , Corbeil J , Sasik R , Khanlou N , et al. 2005. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci USA 102 : 15533-15538. (Pubitemid 41528092)
15. Grof P , Alda M , Grof E , Zvolsky P , Walsh M. 1994. Lithium response and genetics of affective disorders. J Affect Disord 32 : 85-95. (Pubitemid 24306433)
16. Huang DW , Sherman BT , Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4 : 44-57.
17. Isacsson G , Rich CL , Jureidini J , Raven M. 2010. The increased use of antidepressants has contributed to the worldwide reduction in suicide rates. Br J Psychiatry 196 : 429-433.
18. Kemp AH , Gordon E , Rush AJ , Williams LM. 2008. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr 13 : 1066-1086.
19. Kittleson MM , Minhas KM , Irizarry RA , Ye SQ , Edness G , Breton E , et al. 2005. Gene expression in giant cell myocarditis: Altered expression of immune response genes. Int J Cardiol 102 : 333-340. (Pubitemid 40854052)
20. Kubera M , Simbirtsev A , Mathison R , Maes M. 2000. Effects of repeated fl uoxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiatry Res 96 : 255-266.
21. Kubera M , Lin AH , Kenis G , Bosmans E , van BD , Maes M. 2001. Anti-Infl ammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 21 : 199-206. (Pubitemid 32221058)
22. Maes M. 1995. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19 : 11-38.
23. Maes M. 2001. The immunoregulatory effects of antidepressants. Hum Psychopharmacol 16 : 95-103. (Pubitemid 32219729)
24. Malki K , Lourdusamy A , Binder E , Paya-Cano J , Sluyter F , Craig I , et al. 2012. Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression. Pharmacogenet Genomics 22 : 765-776.
25. Mamdani F , Berlim MT , Beaulieu M-M , Labbe A , Merette C , Turecki G. 2011. Gene expression biomarkers of response to citalopram treatment in major depressive disorder. Translational Psychiatry 1 : e13.
26. Marziliano N , Grasso M , Pilotto A , Porcu E , Tagliani M , Disabella E , et al. 2009. Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease? J Cardiovasc Med (Hagerstown ) 10 : 433-442.
27. Matkovich SJ , Van Booven DJ , Youker KA , Torre-Amione G , Diwan A , Eschenbacher WH , et al. 2009. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119 : 1263-1271.
28. Mendlewicz J , Fieve RR , Stallone F , Fleiss JL. 1972. Genetic history as a predictor of lithium response in manic-depressive illness. Lancet 1 : 599-600.
29. Mendlewicz J , Fieve RR , Stallone F. 1973. Relationship between the effectiveness of lithium therapy and family history. Am J Psychiatry 130 : 1011-1013.
30. Mill J , Asherson P , Browes C , D'Souza U , Craig I. 2002. Expression of the dopamine transporter gene is regulated by the 3 ′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114 : 975-979. (Pubitemid 35379243)
31. Murray CJL , Lopez AD. 1998. The global burden of disease. Geneva: WHO.
32. Myint AM , Leonard BE , Steinbusch HW , Kim YK. 2005. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 88 : 167-173. (Pubitemid 41266899)
33. Nagasaki K , Miki Y. 2008. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer. Breast Cancer 15 : 117-120.
34. Nicholson AC , Unger ER , Mangalathu R , Ojaniemi H , Vernon SD. 2004. Exploration of neuroendocrine and immune gene expression in peripheral blood mononuclear cells. Brain Res Mol Brain Res 129 : 193-197. (Pubitemid 39304263)
35. Pare CM , Rees L , Sainsbury MJ. 1962. Differentiation of two genetically specifi c types of depression by the response to antidepressants . Lancet 2 : 1340-1343.
36. Rollins B , Martin MV , Morgan L , Vawter MP. 2010. Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 153B : 919-936.
37. Rush AJ , Trivedi M , Fava M. 2003. Depression, IV: STAR D treatment trial for depression. Am J Psychiatry 160 : 237.
38. Salminen A , Kaarniranta K. 2009. Siglec receptors and hiding plaques in Alzheimer's disease. J Mol Med 87 : 697-701.
39. Schetter AJ , Leung SY , Sohn JJ , Zanetti KA , Bowman ED , Yanaihara N , et al. 2008. MicroRNA expression profi les associated with prognosis and therapeutic outcome in colon adenocarcinoma . JAMA 299 : 425-436. (Pubitemid 351185951)
40. Seidel A , Arolt V , Hunstiger M , Rink L , Behnisch A , Kirchner H. 1996. Increased CD56-natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78 : 83-85.
41. Sequeira A , Gwadry FG , Ffrench-Mullen JM , Canetti L , Gingras Y , Casero RA , Jr., et al. 2006. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 63 : 35-48. (Pubitemid 43037467)
42. Sequeira A , Mamdani F , Ernst C , Vawter MP , Bunney WE , Lebel V , et al. 2009. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 4 : e6585.
43. Serretti A , Franchini L , Gasperini M , Rampoldi R , Smeraldi E. 1998. Mode of inheritance in mood disorder families according to fl uvoxamine response. Acta Psychiatr Scand 98 : 443-450. (Pubitemid 28566294)
44. Sharp FR , Lit L , Xu H , Apperson M , Walker W , Wong B , et al. 2006. Genomics of brain and blood: progress and pitfalls. Epilepsia 47 : 1603-1607. (Pubitemid 44556392)
45. Streiner DL. 2002. Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can J Psychiatry 47 : 262-266. (Pubitemid 34614684)
46. Tang S , Shen YJ , DeBellard ME , Mukhopadhyay G , Salzer JL , Crocker PR , et al. 1997. Myelin-associated glycoprotein interacts with neurons via a sialic acid binding site at ARG118 and a distinct neurite inhibition site. J Cell Biol 138 : 1355-1366. (Pubitemid 27415061)
47. Trivedi MH , Rush AJ , Wisniewski SR , Nierenberg AA , Warden D , Ritz L , et al. 2006. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR D: implications for clinical practice. Am J Psychiatry 163 : 28-40. (Pubitemid 43050100)
48. Wang Y , Neumann H. 2010. Alleviation of neurotoxicity by microglial human Siglec-11. J Neurosci 30 : 3482-3488.
49. Wicks SJ , Grocott T , Haros K , Maillard M , ten DP , Chantry A. 2006. Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway. Biochem Soc Trans 34 : 761-763. (Pubitemid 44796415)
50. Zembutsu H , Suzuki Y , Sasaki A , Tsunoda T , Okazaki M , Yoshimoto M , et al. 2009. Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profi ling. Int J Oncol 34 : 361-370.